"We maintain a constructive view on U.S. equities in 2016 due to (1) steady economic growth in global developed economies, (2) easier year-over-year earnings comparisons (3) expectations of a moderate pace on hawkish moves from the U.S. Federal Reserve," Schoenstein said.
One of his top picks is diversified global healthcare company Becton Dickinson. "We believe that Becton benefits from a distinct scale advantage in its core needles and syringes business," Schoenstein said.
John Augustine, chief investment officer of The Huntington Trust, is also sticking with homegrown companies.
"We will evaluate international vs. domestic in the spring/summer. For now, [we] favor domestic," Augustine said.
Becton Dickinson, Raytheon, Northrop Grumman, Marriott International and AT&T are higher during trading.